Monday, April 10, 2006


Nabi Biopharmaceuticals Acquires Exclusive North American ...


Nabi Biopharmaceuticals Acquires Exclusive North American ...
Yahoo! News (press release) - Apr 3, 2006... Nabi Biopharmaceuticals' complementary product, Civacir [Hepatitis C Immune Globulin (Human)], is being developed to prevent re-infection with the hepatitis ...

Antibodies Neutralizing Peginterferon Alfa during Retreatment of ...
New England Journal of Medicine (subscription), MA - Mar 22, 2006To the Editor: Peginterferons are widely used to treat chronic hepatitis C virus (HCV) infection, an important cause of liver cirrhosis and hepatocellular ...